✦ LIBER ✦

Postprogression Survival in Patients With Advanced Non–Small-Cell Lung Cancer Who Receive Second-Line or Third-Line Chemotherapy

✍ Scribed by Hayashi, Hidetoshi; Okamoto, Isamu; Taguri, Masataka; Morita, Satoshi; Nakagawa, Kazuhiko

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with weekly pac

✍ Luis Ángel León Mateos; Juan Fernando Cueva Bañuelos; María Teresa Curiel García 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 49 KB

Second-line chemotherapy in relapsing or

✍ Georgoulias, Vassilis A 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Second line chemotherapy (CT) in advance

✍ Westeel, V.; Jacoulet, P.; Dubiez, A.; Polio, J.C.; Pemet, D.; Depierre, A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Third-line or fourth-line chemotherapy i

✍ Yuh-Min Chen; Jen-Fu Shih; Wen-Chien Fan; Chieh-Hung Wu; Kun-Ta Chou; Chun-Ming 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 302 KB

Prognostic factors of second-line chemot

✍ Chang, J.H. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 85 KB

Clinical surrogate markers of survival i

✍ Cedrés, Susana; Prat, Aleix; Martínez, Pablo; Pallisa, Esther; Sala, Gemma; Andr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 341 KB